Evidence map›Paper›PMID 39703318›Full record

ArticleCureus2024

Milia En Plaque After Bullous Pemphigoid: An Unusual Sequela.

Helen Z Chen, Mary A Elhawi, Michael A Selby, Michelle Tarbox

Abstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Helen Z ChenDermatology, Texas Tech University Health Sciences Center, Lubbock, USA.
Mary A ElhawiSchool of Medicine, Texas Tech University Health Sciences Center, Lubbock, USA.
Michael A SelbySchool of Medicine, Texas Tech University Health Sciences Center, Lubbock, USA.
Michelle TarboxDermatology, Texas Tech University Health Sciences Center, Lubbock, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present the case of a 36-year-old paraplegic woman with a history of spinal cord injury who developed a generalized blistering rash, later diagnosed as bullous pemphigoid (BP). During her hospitalization, she was treated with prednisone and rituximab infusions, transitioning to maintenance therapy with topical steroids, doxycycline, and nicotinamide. A year later, she presented with concerns about a BP flare on her feet. Examination revealed 1-2 mm white, dome-shaped papules coalescing into erythematous plaques on the plantar surfaces, leading to a diagnosis of milia en plaque (MEP). Treatment with tretinoin 0.05% cream resulted in near-complete resolution within six months. MEP is a rare but benign condition characterized by keratinous cysts on erythematous plaques, often linked to immunobullous disorders such as epidermolysis bullosa acquisita or mucous membrane pemphigoid, and only rarely associated with BP. Distinguishing MEP from active BP is critical, as the latter requires immunosuppressive therapy, while MEP can be managed conservatively. This case underscores MEP as a sequela of BP, highlighting the importance of accurate diagnosis and appropriate management.

Indexed as

autoimmune blistering diseasesbullous pemphigoiddermoscopymiliamilia en plaque

Identifiers

PMID39703318
PMCPMC11658906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.